Literature DB >> 32569776

Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer.

Olabisi Oluwabukola Coker1, William Ka Kai Wu2, Sunny Hei Wong1, Joseph J Y Sung1, Jun Yu3.   

Abstract

BACKGROUND & AIMS: Changes in the intestinal microbiota have been associated with development and progression of colorectal cancer (CRC). Archaea are stable components of the microbiota, but little is known about their composition or contribution to colorectal carcinogenesis. We analyzed archaea in fecal microbiomes of 2 large cohorts of patients with CRC.
METHODS: We performed shotgun metagenomic analyses of fecal samples from 585 participants (184 patients with CRC, 197 patients with adenomas, and 204 healthy individuals) from discovery (165 individuals) and validation (420 individuals) cohorts. Assignment of taxonomies was performed by exact k-mer alignment against an integrated microbial reference genome database.
RESULTS: Principal component analysis of archaeomes showed distinct clusters in fecal samples from patients with CRC, patients with adenomas, and control individuals (P < .001), indicating an alteration in the composition of enteric archaea during tumorigenesis. Fecal samples from patients with CRC had significant enrichment of halophilic and depletion of methanogenic archaea. The halophilic Natrinema sp. J7-2 increased progressively in samples from control individuals, to patients with adenomas, to patients with CRC. Abundances of 9 archaea species that were enriched in fecal samples from patients with CRC distinguished them from control individuals with areas under the receiver operating characteristic curve of 0.82 in the discovery cohort and 0.83 in the validation cohort. An association between archaea and bacteria diversities was observed in fecal samples from control individuals but not from patients with CRC. Archaea that were enriched in fecal samples from patients with CRC had an extensive mutual association with bacteria that were enriched in the same samples and exclusivity with bacteria that were lost from these samples.
CONCLUSIONS: Archaeomes of fecal samples from patients with CRC are characterized by enrichment of halophiles and depletion of methanogens. Studies are needed to determine whether associations between specific archaea and bacteria species in samples from patients with CRC contribute to or are a response to colorectal tumorigenesis.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Microbe; Single-Celled Prokaryote; Stool Sample

Mesh:

Year:  2020        PMID: 32569776     DOI: 10.1053/j.gastro.2020.06.042

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  The human archaeome in focus.

Authors:  Patricia Geesink; Thijs J G Ettema
Journal:  Nat Microbiol       Date:  2022-01       Impact factor: 17.745

Review 2.  Methanogenic archaea in the human gastrointestinal tract.

Authors:  Christoph Hoegenauer; Heinz F Hammer; Alexander Mahnert; Christine Moissl-Eichinger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-01       Impact factor: 73.082

Review 3.  Gut microbiome in gastrointestinal cancer: a friend or foe?

Authors:  Yang Liu; Yoshifumi Baba; Takatsugu Ishimoto; Xi Gu; Jun Zhang; Daichi Nomoto; Kazuo Okadome; Hideo Baba; Peng Qiu
Journal:  Int J Biol Sci       Date:  2022-06-21       Impact factor: 10.750

4.  Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer.

Authors:  Xi-Zhen Sun; Dong-Yan Zhao; Yuan-Chen Zhou; Qian-Qian Wang; Geng Qin; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

Review 5.  Gut microbiota: impacts on gastrointestinal cancer immunotherapy.

Authors:  Harry Cheuk Hay Lau; Joseph Jao-Yiu Sung; Jun Yu
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 6.  Challenges and Perspective in Integrated Multi-Omics in Gut Microbiota Studies.

Authors:  Eric Banan-Mwine Daliri; Fred Kwame Ofosu; Ramachandran Chelliah; Byong H Lee; Deog-Hwan Oh
Journal:  Biomolecules       Date:  2021-02-17

7.  Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.

Authors:  Ning-Ning Liu; Na Jiao; Jing-Cong Tan; Ziliang Wang; Dingfeng Wu; An-Jun Wang; Jie Chen; Liwen Tao; Chenfen Zhou; Wenjie Fang; Io Hong Cheong; Weihua Pan; Wanqing Liao; Zisis Kozlakidis; Christopher Heeschen; Geromy G Moore; Lixin Zhu; Xingdong Chen; Guoqing Zhang; Ruixin Zhu; Hui Wang
Journal:  Nat Microbiol       Date:  2022-01-27       Impact factor: 30.964

8.  An Integrative Approach to Characterize the Early Phases of Dimethylhydrazine-Induced Colorectal Carcinogenesis in the Rat.

Authors:  Rita Silva-Reis; Catarina Castro-Ribeiro; Mariana Gonçalves; Tiago Ferreira; Maria João Pires; Carlos E Iglesias-Aguirre; Adrián Cortés-Martín; María V Selma; Juan Carlos Espín; Elisabete Nascimento-Gonçalves; Alexandra Moreira-Pais; Maria J Neuparth; Francisco Peixoto; Eduardo Rosa; Adelina Gama; Rita Ferreira; Paula A Oliveira; Ana I Faustino-Rocha
Journal:  Biomedicines       Date:  2022-02-09

Review 9.  Microbial-Driven Immunological Memory and Its Potential Role in Microbiome Editing for the Prevention of Colorectal Cancer.

Authors:  Laure Campillo-Gimenez; David Rios-Covian; Jesus Rivera-Nieves; Hiroshi Kiyono; Hiutung Chu; Peter B Ernst
Journal:  Front Cell Infect Microbiol       Date:  2021-11-12       Impact factor: 5.293

Review 10.  Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression.

Authors:  Edgar Torres-Maravilla; Anne-Sophie Boucard; Amir Hossein Mohseni; Sedigheh Taghinezhad-S; Naima G Cortes-Perez; Luis G Bermúdez-Humarán
Journal:  Microorganisms       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.